COVID-19 represents the most recent example of health disparity among Black patients in America. This EBM Focus article discusses a study evaluating this inequity.
EBM Focus: Black Patients May Be at Increased Risk of COVID-19 Hospitalization and Death
July 08, 2020
Is remdesivir the miracle drug we need for COVID-19? Read DynaMed’s EBM Focus to find out.
EBM Focus: Remdesivir for COVID-19 May Speed Time to Recovery but Mortality Benefit Uncertain
June 22, 2020
What do we know about convalescent plasma therapy (CPT) for COVID-19? Read this new EBM Focus article to find out.
EBM Focus: Convalescent Plasma Therapy for COVID-19 — Hope or Hype?
June 11, 2020
In this EBM Focus article, we delve into the hypothesis that ACE inhibitors could be associated with severe COVID-19, and a study that lets ACE inhibitors off the hook.
EBM Focus: It’s Not the ACE Inhibitors that are killing people with COVID-19
May 19, 2020
Hydroxychloroquine (with or without azithromycin) has received a lot of media attention for the treatment of COVID-19, but is there evidence that it works?
An EBM Perspective on Hydroxychloroquine and Azithromycin for the Treatment of COVID-19
April 27, 2020
In this unique EBM Focus article, the DynaMed team answers ten frequently asked questions about coronavirus disease 2019 (COVID-19).
COVID-19: Ten Things You Need to Know
April 09, 2020
In this EBM Focus, a new evaluation of isolated diastolic hypertension (IDH) in the U.S. shows higher prevalence with the AHA/ACC definition compared to JNC7, but no difference in mortality.
EBM Focus: In Another Episode of Overdiagnosis…
March 18, 2020
A new study evaluates aspirin for secondary prevention of cardiovascular disease among a more racially diverse population than previous studies.
EBM Focus: Take Two-Seven Aspirin and Call Me in a Week
March 04, 2020
In this EBM Focus, read about a new trial showing that lemborexant significantly improves sleep onset and maintenance in older adults with insomnia.
EBM Focus: Can’t Sleep? Read This
February 10, 2020
A new study evaluates whether nighttime dosing of antihypertensive drugs exerts better blood pressure control and reduces cardiovascular outcomes.
EBM Focus: Putting Morning Meds for Hypertension to Bed – Nighttime Dosing Seems Better
February 06, 2020
© 2020 EBSCO Information Services. All rights reserved